In a prespecified secondary analysis of 522 high bleeding risk patients in SELUTION DeNovo, a sirolimus-eluting balloon strategy vs systematic DES gave 1-year target vessel failure of 4.9% vs 7.9% (RD -3.05%, 95% CI -7.27 to 1.17), not significantly different; not powered.
Secondary analysisn = 522
Rissanen et al. Percutaneous coronary intervention using sirolimus-eluting balloons in patients at high bleeding risk: the SELUTION DeNovo HBR substudy